SpineGuard SA announced sales results for the first quarter of 2022. For the quarter, the company reported global revenue of 1,131,000 against 1,049,000, 7.9% increase as reported in a context significantly impacted by the Omicron variant peaks of infection in January and February.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2235 EUR | -2.83% | -6.29% | +11.97% |
Apr. 17 | SpineGuard SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | SpineGuard SA announced that it expects to receive ?1.998 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+11.97% | 11.69M | |
+73.17% | 12.34B | |
-18.74% | 7.96B | |
+16.15% | 7.16B | |
+4.81% | 5.72B | |
+5.99% | 5.03B | |
+27.07% | 4.35B | |
-21.67% | 3.99B | |
-40.82% | 2.21B | |
+1.49% | 2.01B |
- Stock Market
- Equities
- ALSGD Stock
- News SpineGuard
- SpineGuard SA Announces Sales Results for the First Quarter of 2022